|
End-of-day quote
New Zealand S.E.
2026-09-07
|
5-day change | 1st Jan Change | ||
| 4.340 NZD | -0.69% |
|
-2.25% | +28.40% |
| 07-31 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 07-31 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 455M 268M 230M 216M 198M 369M 25.3B 371M 2.57B 992M 12.96B 1B 983M 41.28B | P/E 2027 * |
23.1x | P/E 2028 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 485M 285M 245M 231M 211M 394M 26.96B 395M 2.73B 1.06B 13.81B 1.07B 1.05B 43.98B | EV / Sales 2027 * |
1.6x | EV / Sales 2028 * | 1.39x |
| Free-Float |
22.37% | Yield 2027 * |
0.75% | Yield 2028 * | 0.96% |
| Markets | Quality | ||
|---|---|---|---|
New Zealand S.E.
| AFT | End-of-day quote | |
Australian S.E.
| AFP | Delayed |
Last Transcript : AFT Pharmaceuticals Limited
| 24-01-20 | Rentevrees zet Bel20 onder druk | |
| 24-01-19 | KBC uitblinker op groene beurs | |
| 24-01-19 | Brusselse beurs opent flink hoger | |
| 24-01-19 | Brussel start handelsdag vermoedelijk in het groen | |
| 24-01-18 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | -0.69% | ||
| 1 week | -2.25% | ||
| Current month | -2.25% | ||
| 1 month | -7.66% | ||
| 3 months | +11.00% | ||
| 6 months | +24.00% | ||
| Current year | +28.40% |
| 1 week | 4.32 |  | 4.44 |
| 1 month | 4.23 | | 4.68 |
| Current year | 3.35 | | 4.85 |
| 1 year | 2.56 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 2012-09-03 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 1997-09-03 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 2026-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 2015-06-21 |
Hartley Atkinson
BRD | Director/Board Member | - | 1997-09-03 |
Marree Atkinson
BRD | Director/Board Member | - | 2012-09-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 6/26/25 | Free | Founder | 17,755 | 0.0169% | ||
| 12/2/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | -2.25% | +60.74% | +25.43% | 270M | |
| -0.88% | -0.64% | +58.05% | +100.51% | 1,024B | |
| -1.15% | +3.53% | +54.25% | +71.99% | 663B | |
| -1.44% | +0.02% | +20.65% | +72.22% | 453B | |
| -0.95% | +0.23% | +28.96% | +37.78% | 352B | |
| -3.18% | +1.78% | +20.66% | +41.55% | 304B | |
| +0.30% | +0.60% | -0.40% | +11.25% | 252B | |
| -1.55% | +1.71% | +54.15% | +71.87% | 236B | |
| +0.02% | +2.24% | -14.59% | -55.80% | 206B | |
| -0.15% | +3.18% | +31.24% | +104.21% | 187B | |
| Average | -0.97% | +1.01% | +31.37% | +48.10% | 367.86B | |
| Weighted average by Cap. | -1.07% | +0.64% | +37.21% | +64.50% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 179M 154M 144M 132M 247M 16.89B 247M 1.71B 662M 8.65B 671M 656M 27.55B | 345M 203M 175M 164M 150M 280M 19.19B 281M 1.95B 752M 9.83B 762M 746M 31.31B |
| Net income | 19.7M 11.58M 9.96M 9.37M 8.55M 15.99M 1.09B 16.04M 111M 42.92M 561M 43.48M 42.53M 1.79B | 24.81M 14.59M 12.54M 11.8M 10.77M 20.14M 1.38B 20.21M 140M 54.07M 706M 54.78M 53.58M 2.25B |
| Net Debt | 29.84M 17.54M 15.08M 14.19M 12.95M 24.22M 1.66B 24.3M 168M 65.02M 849M 65.87M 64.43M 2.71B | 24.6M 14.46M 12.44M 11.7M 10.68M 19.97M 1.37B 20.03M 139M 53.6M 700M 54.3M 53.11M 2.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | NZ$4.340 | -0.69% | 8,724 |
| 26-09-04 | NZ$4.370 | -0.23% | 2,192 |
| 26-09-03 | NZ$4.380 | +0.69% | 36,563 |
| 26-09-02 | NZ$4.350 | -1.36% | 12,353 |
| 26-09-01 | NZ$4.410 | -0.68% | 27,717 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
